Gufic BioSciences Ltd. Investor Presentation

Gufic BioSciences Ltd. Investor Presentation: Get insights into company performance, financials, capex plans and more

Quarter

Conference/Earnings Calls Alerts

Search Inside the pdf :

Gufic BioSciences Ltd.

13 Aug 2025

370.40

3.70%

Investor Presentation

Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation on Unaudited Financial Results of the Company for the quarter ended June 30, 2025 is attached herewith

Gufic BioSciences Ltd.

30 May 2025

370.40

3.70%

Investor Presentation

Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation on Audited Financial Results of the Company for the quarter and financial year ended March 31, 2025 is attached herewith

Gufic BioSciences Ltd.

14 Feb 2025

370.40

3.70%

Investor Presentation

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation is attached herewith.

Gufic BioSciences Ltd.

14 Nov 2024

370.40

3.70%

Investor Presentation

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation is attached herewith.

Gufic BioSciences Ltd.

14 Aug 2024

370.40

3.70%

Investor Presentation

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation on Unaudited Financial Results of the Company for the quarter ended June 30, 2024 is attached herewith.

Gufic BioSciences Ltd.

29 May 2024

370.40

3.70%

Investor Presentation

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation on Audited Financial Results of the Company for the quarter and financial year ended March 31, 2024 is attached herewith.

Gufic BioSciences Ltd.

14 Feb 2024

370.40

3.70%

Investor Presentation

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation on Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2023 is attached herewith.

Gufic BioSciences Ltd.

17 Nov 2023

370.40

3.70%

Investor Presentation

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the Investor Presentation on Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2023.

Gufic BioSciences Ltd.

11 Aug 2023

370.40

3.70%

Investor Presentation

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Investor Presentation on Unaudited Financial Results of the Company for the Quarter ended June 30, 2023.

Gufic BioSciences Ltd.

29 May 2023

370.40

3.70%

Investor Presentation

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Investor Presentation on Audited Financial Results of the Company for the quarter and financial year ended March 31, 2023